{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:32:07Z","timestamp":1791977527130,"version":"4.4.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10072-022-06046-3","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T18:03:51Z","timestamp":1649354631000},"page":"4567-4570","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A case of anti-HMGCR myopathy triggered by sodium\/glucose co-transporter 2 (SGLT2) inhibitors"],"prefix":"10.1007","volume":"43","author":[{"given":"Manuela","family":"Stella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Biassoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Fiorillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Grandis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8460-0262","authenticated-orcid":false,"given":"Francesca","family":"Mattioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Del Sette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,7]]},"reference":[{"key":"6046_CR1","unstructured":"Orphanet - The portal for rare diseases and orphan drugs. https:\/\/www.orpha.net\/consor\/cgi-bin\/OC_Exp.php?lng=EN&Expert=206569. Accessed 21 Jan 2022"},{"key":"6046_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3233\/JND-170282","volume":"5","author":"P Mohassel","year":"2018","unstructured":"Mohassel P, Mammen AL (2018) Anti-HMGCR myopathy. J Neuromuscul Dis 5:11\u201320. https:\/\/doi.org\/10.3233\/JND-170282","journal-title":"J Neuromuscul Dis"},{"key":"6046_CR3","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1007\/s13311-018-00676-2","volume":"15","author":"ER McGrath","year":"2018","unstructured":"McGrath ER, Doughty CT, Amato AA (2018) Autoimmune myopathies: updates on evaluation and treatment. Neurotherapeutics 15:976\u2013994. https:\/\/doi.org\/10.1007\/s13311-018-00676-2","journal-title":"Neurotherapeutics"},{"key":"6046_CR4","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1056\/NEJMra1515161","volume":"374","author":"AL Mammen","year":"2016","unstructured":"Mammen AL (2016) Statin-associated autoimmune myopathy. N Engl J Med 374:664\u2013669. https:\/\/doi.org\/10.1056\/NEJMra1515161","journal-title":"N Engl J Med"},{"key":"6046_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11926-015-0548-6","volume":"17","author":"P Basharat","year":"2015","unstructured":"Basharat P, Christopher-Stine L (2015) Immune-mediated necrotizing myopathy: update on diagnosis and management. Curr Rheumatol Rep 17:72. https:\/\/doi.org\/10.1007\/s11926-015-0548-6","journal-title":"Curr Rheumatol Rep"},{"key":"6046_CR6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/MD.0000000000000028","volume":"293","author":"Y Allenbach","year":"2014","unstructured":"Allenbach Y, Drouot L, Rigolet A, Charuel JL, Jouen F, Romero NB, Maisonobe T, Dubourg O, Behin A, Laforet P, Stojkovic T, Eymard B, Costedoat-Chalumeau N, Campana-Salort E, Tournadre A, Musset L, Bader-Meunier B, Kone-Paut I, Sibilia J et al (2014) Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin. Medicine (Baltimore) 293:150\u2013157. https:\/\/doi.org\/10.1097\/MD.0000000000000028","journal-title":"Medicine (Baltimore)"},{"key":"6046_CR7","first-page":"75","volume":"25","author":"BL Adler","year":"2018","unstructured":"Adler BL, Christopher-Stine L (2018) Triggers of inflammatory myopathy: insights into pathogenesis. Discov Med 25:75\u201383","journal-title":"Discov Med"},{"key":"6046_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11926-010-0104-3","volume":"12","author":"R Valiyil","year":"2010","unstructured":"Valiyil R, Christopher-Stine L (2010) Drug-related myopathies of which the clinician should be aware. Curr Rheumatol Rep 12:213\u2013220. https:\/\/doi.org\/10.1007\/s11926-010-0104-3","journal-title":"Curr Rheumatol Rep"},{"key":"6046_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239\u2013245. https:\/\/doi.org\/10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"6046_CR10","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1136\/jnnp-2016-313418","volume":"87","author":"MC Dalakas","year":"2016","unstructured":"Dalakas MC (2016) Necrotising autoimmune myopathy (NAM): antibodies seem to be specific markers in aiding diagnosis. J Neurol Neurosurg Psychiatry 87:1037. https:\/\/doi.org\/10.1136\/jnnp-2016-313418","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6046_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1517\/14740338.1.1.65","volume":"1","author":"B Bannwarth","year":"2002","unstructured":"Bannwarth B (2002) Drug-induced myopathies. Expert Opin Drug Saf 1:65\u201370. https:\/\/doi.org\/10.1517\/14740338.1.1.65","journal-title":"Expert Opin Drug Saf"},{"key":"6046_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/BJMMR\/2017\/33253","volume":"21","author":"UM Kabadi","year":"2017","unstructured":"Kabadi UM (2017) Marked weight loss, muscle wasting and fatigue on administration of empagliflozin in a subject with type 2 diabetes. J Adv Med Med Res 21:1\u20137","journal-title":"J Adv Med Med Res"},{"key":"6046_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1530\/EDM-20-0017","volume":"2020","author":"F Gao","year":"2020","unstructured":"Gao F, Hall S, Bach LA (2020) Myopathy secondary to empagliflozin therapy in type 2 diabetes. Endocrinol Diabetes Metab Case Rep 2020:20\u20130017. https:\/\/doi.org\/10.1530\/EDM-20-0017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"6046_CR14","doi-asserted-by":"publisher","first-page":"100765","DOI":"10.1016\/j.cpcardiol.2020.100765","volume":"46","author":"R Gupta","year":"2021","unstructured":"Gupta R, Alcantara R, Popli T, Mahajan S, Tariq U, Dusaj RS, Malik AH (2021) Myopathy associated with statins and SGLT2 - a review of literature. Curr Probl Cardiol 46:100765. https:\/\/doi.org\/10.1016\/j.cpcardiol.2020.100765","journal-title":"Curr Probl Cardiol"},{"key":"6046_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.36185\/2532-1900-031","volume":"39","author":"FL Mastaglia","year":"2020","unstructured":"Mastaglia FL (2020) The changing spectrum of drug-induced myopathies. Acta Myol 39:283\u2013288. https:\/\/doi.org\/10.36185\/2532-1900-031","journal-title":"Acta Myol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06046-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-022-06046-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06046-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T04:09:39Z","timestamp":1655784579000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-022-06046-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,7]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["6046"],"URL":"https:\/\/doi.org\/10.1007\/s10072-022-06046-3","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,7]]},"assertion":[{"value":"6 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the patient involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}